# Sindas (NCT02893332)

> Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02893332
- Phase: PHASE3
- Status: TERMINATED
- Sponsor: Sichuan Provincial People's Hospital
- Conditions: Stage IV EGFR Mutated Non-Small Cell Lung Cancer
- Interventions: Radiation: SBRT; TKI (Gefitinib or Tarceva )
- Enrollment: 200
- Primary outcome: Progression free survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 38
- YouTube: 3
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=sindas-nct02893332

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02893332", "email": "<work email>"}; the inbox owner confirms by the emailed link.